Skip to Content

← See all SENEXON brands

SENEXON by Avera McKennan Hospital

Medically reviewed on December 15, 2017

Dosage form: tablet, coated
Ingredients: SENNOSIDES A and B 8.6mg
Labeler: Avera McKennan Hospital
NDC Code: 69189-5904

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active ingredient (in each tablet) Sennosides 8.6mg

Ask a doctor or pharmacist before use if you are taking any other drug.  Take this product tow or more hours before or after other drugs.  Laxatives may affect how other drugs work.

Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks.

Do not use for longer than one week, when abdominal pain, nausea or vomiting are present.

Stop use and ask a doctor if: you have rectal bleeding; you fail to have a bowel movement after use of this product.  These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

uses

relieves occasional constipation(irregularity);generally causes bowel movement in 6-12 hours.

1800 645-2158 9 am - 5 pm Monday - Friday

 Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

Inactive Ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, minerol  oil

Dosage and Administration

Adults and children 12 years and over - 2 tablets once a day - maximum dosage - 4 tablets twice a day

Children 6 to under 12 years - 1 tablet once a day maximum dosage - 2 tablets twice a day

children 2 to under 6 years - 1/2 tablet once a day - maximum dosage - 1 tablet twice a day

Relieves occasional constipation

Generally produces bowel movement in 6-12 hours

SENEXON 
senna tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69189-5904(NDC:0536-5904)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A and B (SENNOSIDES A and B) SENNOSIDES A and B8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
DIBASIC CALCIUM PHOSPHATE DIHYDRATE 
HYPROMELLOSE 2910 (6 MPA.S) 
magnesium stearate 
CELLULOSE, MICROCRYSTALLINE  
mineral oil 
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize9mm
FlavorImprint CodeTCL080
Contains    
Packaging
#Item CodePackage Description
1NDC:69189-5904-11 TABLET, COATED in 1 DOSE PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33411/02/2015
Labeler - Avera McKennan Hospital (068647668)
Establishment
NameAddressID/FEIOperations
Avera McKennan Hospital068647668relabel(69189-5904), repack(69189-5904)

 
Avera McKennan Hospital

← See all SENEXON brands

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide